Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources

Major Programs

The Division of Cancer Prevention supports major scientific collaborations and research networks at more than100 sites across the United States; investigator-initiated grants; postdoctoral training; and specialized resources for researchers.

Alliance of Glycobiologists for Detection of Cancer

Tumor Glycomics Laboratories reveal cancer-related dynamics of carbohydrates for development of validated clinical biomarkers for early detection.

Barrett's Esophagus Translational Research Network (BETRNet)

Multidisciplinary translational research centers collaborate to better understand the biology of Barrett's esophagus and esophageal adenocarcinoma to improve risk stratification and develop prevention strategies.

Cancer Prevention Fellowship Program (CPFP)

Postdoctoral opportunities provide training in cancer prevention and control to individuals from a multiplicity of health sciences disciplines.

Early Detection Research Network (EDRN)

Public and private sector collaborations accelerate the translation of biomarker information and technologies into clinical applications.

NCI Community Oncology Research Program (NCORP)

A national network of cancer care investigators, providers, academia, and other organizations that will conduct multi-site studies in diverse populations in healthcare systems across the United States.

Phase 0/I/II Cancer Prevention Clinical Trials Program
(Consortia for Early Phase Prevention Trials)

Six cancer research centers lead multiple collaborative networks to assess potential cancer prevention agents through Phase I and II clinical trials.

PREVENT Cancer Preclinical Drug Development Program

This unique partnership facilitates cancer preventive drug development and clinical trials.

Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial is a large population-based randomized trial designed and sponsored by the National Cancer Institute (NCI) to determine the effects of screening on cancer-related mortality and secondary endpoints in men and women aged 55 to 74.

Supportive & Palliative Care Research

Prevents, manages, or treats the symptoms related to cancer, its treatment, quality of life, and at the end of life.

Back to top